Stephanie Harlfinger

Head of Global New Chemical Entities & Drug Metabolism, Pharmacokinetics Merck KGaA

Seminars

Wednesday 17th March 2027
Speaking at the 7th TPD & Induced Proximity Summit Europe
Stephanie Harlfinger